Taking your company public through an IPO is a crucial step, presenting a unique opportunity to benefit both your business and its investors. Explore the Nasdaq IPO Academy, a program tailored to ...

Median returns three months post IPO 2024 performance (the green line in Chart 5) were much better than the last two years (purple and pink lines). Importantly, 2024 IPOs as a group have so far held ...

Mills credited SailPoint's long-time CEO Mark McClain with keeping the ship steady throughout the IPO journey, calling him "a ...

Leaders at the New York Stock Exchange and Nasdaq also predict a bigger year for IPOs in 2025. "Nasdaq CEO Adena Friedman expects IPOs to return with momentum this year," Haslett notes.

Clearly, if you had been lucky enough to pick up some shares at the company’s IPO price, you would have ... perform relative to some other popular stocks? Also, find out which stocks you should ...

The total gross proceeds of $10,125,000 from the initial public offering may be considered low for a company looking to establish a significant presence on the Nasdaq Capital Market. The offering ...

Investors in defense stocks seem a bit nervous at the prospect ... Well, simply put, because Anduril might IPO soon. Since its establishment in 2017 (by, among others, Oculus founder Palmer ...

Metsera, Inc MTSR IPO will take place January, 31 on the NASDAQ exchange under the ticker MTSR. The company is offering shares at an expected price between $15.00 and $17.00 per share with an ...

Nasdaq CEO Adena Friedman is optimistic that President Trump’s administration will offer a chance to relook regulations in the US to attract more companies to tap public markets. Speaking during ...

(RTTNews) - Maze Therapeutics, Inc., (MAZE), a clinical-stage biopharmaceutical company focused on developing small molecule precision medicines, has priced its initial public offering or IPO of 8 ...

OrbiMed Advisors LLC, a director at Sionna Therapeutics , Inc. (NASDAQ:SION), has made significant stock purchases, according to a recent filing. On February 10, 2025, OrbiMed acquired 550,000 shares ...